Marcia Belvin
CytomX Therapeutics (United States)(US)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Melanoma and MAPK Pathways, Advanced Breast Cancer Therapies, Chronic Lymphocytic Leukemia Research, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth(2010)1,616 cited
- → A CONSERVED SIGNALING PATHWAY: The Drosophila Toll-Dorsal Pathway(1996)834 cited
- → Systematic generation of high-resolution deletion coverage of the Drosophila melanogaster genome(2004)770 cited
- → MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade(2016)715 cited
- → The Drosophila immune response against Gram-negative bacteria is mediated by a peptidoglycan recognition protein(2002)680 cited
- → Dual Detection of Fungal Infections in Drosophila via Recognition of Glucans and Sensing of Virulence Factors(2006)507 cited